Min, are you EV's right? Last quarterly had $15M cash and then raised more recently. EMR has a wad of cash that RNS doesn't hence why EMR worth more.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%